Bio pharmaceutical company
H.R.8855/S.4866 - Sickle Cell Disease Treatment Centers Act of 2022.
HCR - Health Issues
34 - Health & Human Services, Dept of (HHS) 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
IRENE BUENO LISA GERMAN FOSTER EDEN SHIFERAW